NTV Asset Management LLC Invests $2.80 Million in Tempus AI, Inc. $TEM

NTV Asset Management LLC purchased a new position in shares of Tempus AI, Inc. (NASDAQ:TEM) during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 44,017 shares of the company’s stock, valued at approximately $2,797,000.

A number of other large investors have also made changes to their positions in TEM. Vanguard Group Inc. increased its position in shares of Tempus AI by 6,247.5% during the first quarter. Vanguard Group Inc. now owns 5,995,117 shares of the company’s stock worth $289,204,000 after purchasing an additional 5,900,668 shares in the last quarter. ARK Investment Management LLC increased its position in shares of Tempus AI by 35.9% in the 1st quarter. ARK Investment Management LLC now owns 7,501,399 shares of the company’s stock valued at $361,867,000 after acquiring an additional 1,981,755 shares during the period. Nikko Asset Management Americas Inc. increased its position in shares of Tempus AI by 31.5% in the 1st quarter. Nikko Asset Management Americas Inc. now owns 4,260,553 shares of the company’s stock valued at $205,401,000 after acquiring an additional 1,021,460 shares during the period. Sumitomo Mitsui Trust Group Inc. increased its position in shares of Tempus AI by 31.4% in the 1st quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,255,477 shares of the company’s stock valued at $205,284,000 after acquiring an additional 1,016,384 shares during the period. Finally, CloudAlpha Capital Management Limited Hong Kong acquired a new position in shares of Tempus AI in the 1st quarter valued at $34,119,000. 24.22% of the stock is owned by institutional investors and hedge funds.

Tempus AI Price Performance

NASDAQ:TEM opened at $91.66 on Friday. Tempus AI, Inc. has a one year low of $31.36 and a one year high of $97.79. The company has a debt-to-equity ratio of 2.58, a quick ratio of 1.43 and a current ratio of 1.54. The firm has a market cap of $15.92 billion, a price-to-earnings ratio of -77.03 and a beta of 4.87. The firm’s fifty day moving average is $74.98 and its two-hundred day moving average is $63.18.

Tempus AI (NASDAQ:TEM) last posted its quarterly earnings results on Friday, August 8th. The company reported ($0.22) EPS for the quarter, beating the consensus estimate of ($0.23) by $0.01. Tempus AI had a negative net margin of 20.98% and a negative return on equity of 122.86%. The company had revenue of $314.64 million for the quarter, compared to analyst estimates of $296.84 million. During the same period in the prior year, the company earned ($6.86) earnings per share. The firm’s revenue was up 89.5% on a year-over-year basis. Tempus AI has set its FY 2025 guidance at EPS. Research analysts expect that Tempus AI, Inc. will post -6.15 EPS for the current year.

Insider Buying and Selling

In other news, EVP Erik Phelps sold 3,664 shares of the stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $74.65, for a total transaction of $273,517.60. Following the sale, the executive vice president directly owned 94,115 shares of the company’s stock, valued at $7,025,684.75. This represents a 3.75% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Eric P. Lefkofsky sold 332,500 shares of the stock in a transaction dated Thursday, September 25th. The stock was sold at an average price of $76.56, for a total transaction of $25,456,200.00. Following the sale, the chief executive officer directly owned 9,141,032 shares in the company, valued at approximately $699,837,409.92. The trade was a 3.51% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 933,662 shares of company stock valued at $67,909,393 in the last 90 days. 26.27% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several research firms recently issued reports on TEM. Weiss Ratings reissued a “sell (d-)” rating on shares of Tempus AI in a research report on Saturday, September 27th. HC Wainwright upped their target price on Tempus AI from $90.00 to $98.00 and gave the company a “buy” rating in a research report on Friday, September 12th. Bank of America upped their target price on Tempus AI from $68.00 to $70.00 and gave the company a “neutral” rating in a research report on Wednesday, June 25th. BTIG Research upped their target price on Tempus AI from $75.00 to $85.00 and gave the company a “buy” rating in a research report on Wednesday, August 20th. Finally, Piper Sandler reissued a “neutral” rating on shares of Tempus AI in a research report on Friday, August 8th. Seven equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Tempus AI currently has an average rating of “Hold” and a consensus price target of $71.83.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.